Table 1 Clinical characteristics of 28 patients with LA-NPC
Characteristics | Control group | Experimental group | p |
|---|---|---|---|
N | 14 | 14 | |
Sex, n (%) | 0.678 | ||
Female | 3 (21.43%) | 5 (35.71%) | |
Male | 11 (78.57%) | 9 (64.29%) | |
Age (years), mean ± SD | 47.79 ± 7.82 | 42.71 ± 11.19 | 0.176 |
Histologic subtypes, n (%) | |||
Undifferentiated carcinoma | 14(100%) | 14(100%) | 1.000 |
T stage, n (%) | 0.042 | ||
T2 | 2 (14.29%) | 0 (0%) | |
T3 | 1 (7.14%) | 6 (42.86%) | |
T4 | 11 (78.57%) | 8 (57.14%) | |
N stage, n (%) | 0.775 | ||
N1 | 4 (28.57%) | 3 (21.43%) | |
N2 | 8 (57.14%) | 7 (50.0%) | |
N3 | 2 (14.29%) | 4 (28.57%) | |
Clinical stage, n (%) | 1.000 | ||
III | 2 (14.29%) | 2 (14.29%) | |
IVa | 12 (85.71%) | 12 (85.71%) | |
EBV-DNA copies/ml after radiotherapy | 0.549 | ||
Positive | 3(21.43%) | 4(28.57%) | |
Negative | 11 (78.57%) | 10(71.43%) |